ENTADFI is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Veru Inc.. The primary component is Tadalafil; Finasteride.
Product ID | 69681-125_3a043550-4704-4da9-a3d4-24c198ca7bf6 |
NDC | 69681-125 |
Product Type | Human Prescription Drug |
Proprietary Name | ENTADFI |
Generic Name | Finasteride And Tadalafil |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2021-12-12 |
Marketing Category | NDA / |
Application Number | NDA215423 |
Labeler Name | Veru Inc. |
Substance Name | TADALAFIL; FINASTERIDE |
Active Ingredient Strength | 5 mg/1; mg/1 |
Pharm Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA],5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-12-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ENTADFI 90882046 not registered Live/Pending |
Veru Inc. 2021-08-13 |
ENTADFI 90830745 not registered Live/Pending |
Veru Inc. 2021-07-15 |